Gelteq (GELS) Cash from Operations (2023 - 2025)
Gelteq's (GELS) quarterly Cash from Operations came in at 710866.45 in Q4 2025, up 69.76% year-on-year from 418747.72 in Q4 2024, and up 69.76% quarter-over-quarter from 2350754.9 in Q4 2024.
Gelteq (GELS) Cash from Operations (2023 - 2025) Analysis & Trends
Gelteq's Cash from Operations history runs 3 years deep, the most recent figure standing at 710866.45 for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Gelteq | 740.00 | -47,821.64 | - | -710,866.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -710,866.45 |
| Dec 31, 2025 | -710,866.45 |
| Dec 31, 2024 | -2.35 Mn |
| Dec 31, 2024 | -2.35 Mn |
| Dec 31, 2023 | -279,386.89 |
| Dec 31, 2023 | -279,386.89 |